Phase
Condition
Williams Syndrome
Vascular Diseases
Ocular Hypertension
Treatment
H-1337 1.0%
H-1337 Placebo
H-1337 0.6%
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of bilateral primary open angle glaucoma or ocular hypertension
Exclusion
Exclusion Criteria:
- Closed or very narrow angles (Grades 0-1) or those the investigator judges asoccludable and/or with evidence of peripheral anterior synechiae >/= 180 degrees bygonioscopy within 6 months prior to screening visit in either eye
Note: Other inclusion/exclusion criteria apply.
Study Design
Connect with a study center
Global Research Management
Glendale, California 91204
United StatesSite Not Available
Skyline Vision Clinic and Laser Center
Colorado Springs, Colorado 80907
United StatesSite Not Available
Central Florida Eye Associates
Lakeland, Florida 33805
United StatesSite Not Available
Shettle Eye Research, Inc.
Largo, Florida 33773
United StatesSite Not Available
Dixon Eye Care
Albany, Georgia 31701
United StatesSite Not Available
Coastal Research Associates, LLC
Roswell, Georgia 30076
United StatesSite Not Available
Rochester Ophthalmological Group, PC
Rochester, New York 14618
United StatesSite Not Available
University Eye Specialists
Maryville, Tennessee 37803
United StatesSite Not Available
Vistar Eye Center
Roanoke, Virginia 24011
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.